The pathological significance of our small-molecule approach, which simultaneously reduced RAS, β-catenin, and EGFR levels, was supported by their correlated overexpression in TNBC patient tumor tissues compared with the adjacent normal mammary glands in our survey using tissue microarray. The gene discussed is EGFR; the disease is neoplasm.